Antibiotic injections show promise for parasitic skin sores

NCT ID NCT06797544

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether injecting the antibiotic levofloxacin directly into skin sores caused by leishmaniasis can cure them. Forty adults with up to seven sores will receive weekly injections for up to six weeks and be monitored for 90 days. The goal is to see if the sores heal completely or mostly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
levofloxacin (an antibiotic) injected directly into the skin lesion
What this could lead to
If it works, this could offer a new, locally injected treatment for cutaneous leishmaniasis, potentially reducing the need for systemic drugs with more side effects.
What could go wrong
This is a small, early-phase trial with only 40 participants and no comparison group, so results may not be conclusive. The treatment may not cure all lesions, and side effects from the injection are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS LEISHMANIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mustansiriyah University

    RECRUITING

    Baghdad, 10047, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.